Just out of curiosity I decided to see what it would cost each of the major shareholders to fund BoM2 assuming a $100,000,000 cost trial based on their proportionate ownership from last June. I’ve left out Don and Dr Wong in this exercise.

The costs to Hepalink and ORI would seem to be quite a stretch, although I’m not familiar with their resources.

The Eastern cost would seem achievable given their resources.

Thoughts?

Buckeyes, keep the long, thoughtful posts coming. It is important for us to gain insight from someone like you with experience in this space and who "can't make sense" of the situation. This says alot.

It is truly a riddle. Might there be some sort of hidden clause in Don's contract that he can't be fired?

Toinv